A A A

News & Medical Papers


For current guidelines and updates from within the arrhythmia healthcare community please visit Arrhythmia Watch.
 

Diploma in Syncope and Related Disorders at the Royal College of Physicians of Ireland

Syncope Trust And Reflex anoxic Seizures (STARS), January 2015
This course is the initiative of STARS Trustee, Professor Rose Ann Kenny and Dr Conal Cunningham. Already the positive feedback and uptake is more than encouraging. Syncope units must be the way forward for the future and for anyone whose hospital is considering this then early registration of interest for 2015 is recommended.

Learn more


2013-14 Cardiac Rhythm Management National Report published

ucl.ac.uk, February 2015
The latest annual report, Heart Rhythm Device Implants and Cardiac Ablation, is now available.
Read online


Portola announces full results from positive phase 3 ANNEXA(TM)-R study demonstrating that andexanet alfa rapidly and significantly reversed anticoagulant effect of factor Xa Inhibitor XARELTO

GlobeNewswire.com, 2 March 2015
Portola Pharmaceuticals (Nasdaq:PTLA) today announced full results from the first part of the Phase 3 ANNEXA™-R (Andexanet Alfa a Novel Antidote to the Anticoagulant Effects of fXa Inhibitors – Rivaroxaban) study, which is evaluating the safety and efficacy of andexanet alfa with the Factor Xa inhibitor XARELTO® (rivaroxaban) in healthy volunteers.
Read more


Many with AF qualify for oral anticoagulation therapy under new guidelines

healio.com, 2 March 2015
Most patients with atrial fibrillation not recommended for oral anticoagulation under previous guidelines are now eligible for therapy based on the newest guidelines, according to a report published in JAMA Internal Medicine.
Read more


Boehringer Ingelheim files BLA for antidote to dabigatran

healio.com, 2 March 2015
Boehringer Ingelheim announced that it has submitted a biologics license application to the FDA requesting an accelerated approval pathway for idarucizumab, an antidote to dabigatran.
Read more


Subcutaneous-ICD patients may be able to undergo MRI scans at 1.5T safely

cxvascular.com, 26 February 2015
Subcutaneous implantable cardioverter-defibrillator patients may be safe to be exposed to magnetic resonance imaging (MRI) procedures at 1.5T with a pre-specified scanning and monitoring protocol.
Read more


New guidance on managing anticoagulant-associated ICH

medscape.com, 27 February 2015
In the acute phase of oral anticoagulation-associated intracerebral hemorrhage (OAC-ICH), two factors can protect against hematoma enlargement: getting the international normalized ratio (INR) below 1.3 and getting the systolic blood pressure (BP) below 160 mm Hg within 4 hours, a new study shows.
Read more


FDA grants orphan drug status to Factor Xa inhibitor antidote

healio.com, 26 February 2015
The FDA has granted orphan drug designation to andexanet alfa for the treatment of patients with serious, uncontrolled bleeding events or who require emergency surgery, according to a press release from the drug’s manufacturer.
Read more


Non-medical ILR implants cost-saving

arwatch.co.uk, 25 February 2015
A service has been developed which can safely insert implantable loop recorders (ILRs) in a non-medical, non-catheter laboratory (cath lab) environment, according to a study published recently in the British Journal of Cardiology.
Read more


AF type is better stroke predictor

arwatch.co.uk, 25 February 2015
Pattern of atrial fibrillation (AF) is a strong independent predictor of stroke risk in non-anticoagulated patients, and may help to assess the risk/benefit for anticoagulant therapy, especially in lower risk patients, according to a study published recently in the European Heart Journal.
Read more


Periprocedural anticoagulants safe for patients undergoing cardioversion or ablation for AF

healio.com, 24 February 2015
Warfarin, dabigatran and rivaroxaban are safe periprocedural anticoagulation options for patients undergoing cardioversion or ablation for atrial fibrillation, according to researchers in Canada.
Read more


Scientists identify key protein behind heart's 'metronome'

medicalnewstoday.com, 23 February 2015
An important feature of a healthy heart is its ability to maintain a steady beat. Even a slight faltering in the heart's rhythm can cause sudden death. Now, a new study identifies a key protein that helps maintain the heart's "metronome."
Read more


Cutting-edge heart model predicts changes in the heart that can lead to AF

hcplive.com, 19 February 2015
A paper from a pair of physicists may reveal significant new information about the causes of atrial fibrillation (AF) and help to make cardiac ablations a more effective treatment for the condition.
Read more


Cardiac or other implantable electronic devices and sleep-disordered breathing - implications for diagnosis and therapy

radcliffecardiology.com, February 2015
Sleep-disordered breathing (SDB) is of growing interest in cardiology because SDB is a highly prevalent comorbidity in patients with a variety of cardiovascular diseases.
Read more


Remote monitoring for follow-up of patients with implantable cardiac electronic devices

radcliffecardiology.com, February 2015
Lead and device performance monitoring is a physician responsibility and represents a challenge due to the number and complexity of implanted systems and the increased number of advisories during the last 10 years.
Read more


Patients with AF, intermediate stroke risk should receive anticoagulation, says group

medscape.com, 18 February 2015
TAIPEI, TAIWAN — For men with atrial fibrillation (AF) who tick at least one box on the CHA2DS2-VASc risk-factor score sheet, the risk of ischemic stroke ranges from 1.96% per year to as high as 3.50%, depending on the specific risk factor composing the score, according to the results of a new analysis.
Read more


Oral anticoagulation recommended for patients with AF, one additional stroke risk factor

healio.com, 16 February 2015
In a real-world cohort of patients in Taiwan, patients with atrial fibrillation and at least one additional risk factor for stroke were at high risk for ischemic stroke and researchers recommended that oral anticoagulation be considered in this patient population.
Read more


Limit Hydroxyzine use to reduce cardiac risks, EU regulators say

medscape.com, 13 February 2015
Physicians should take certain precautions in prescribing the first-generation antihistamine hydroxyzine to minimize the drug’s risk for potentially fatal heart arrhythmias, the European Medicines Agency (EMA) announced today.
Read more


Assessing bleeding and AF-stroke risk to achieve best patient outcome

medscape.com, 13 February 2015
At the 2014 ESC meeting, his group (lead author Dr TF Chao [Taipei Veterans General Hospital, Taiwan]) presented a Taiwanese registry study[7] showing that untreated CHA2DS2-VASc (CHA2DS2-VASc-1 for males, CHA2DS2-VASc-2 for females) patients have annual event rates in the range of 2% to 3% per year.
Read more


Insertable cardiac monitors effective, provide value for poststroke AF

healio.com, 12 February 2015
Two studies of insertable cardiac monitors presented at the International Stroke Conference demonstrated that the devices were effective for the identification of atrial fibrillation in patients previously diagnosed with cryptogenic stroke and cost effective for the prevention of recurrent stroke.
Read more


ENSURE-AF: Largest trial ever to explore novel oral anticoagulation in AF patients undergoing cardioversion

cxvascular.com, 10 February 2015
Results of the X-VERT trial, presented at the European Society of Cardiology meeting (ESC; 30 August–3 September, Barcelona, Spain), showed that rivaroxaban (Bayer/Janssen Pharmaceuticals) appears to be an effective and safe alternative to vitamin K antagonist (VKA) therapy in patients with non-valvular atrial fibrillation who are undergoing elective cardioversion (electrical or pharmacological).
Read more


Phase 3 ANNEXA-R study of andexanet alfa and factor Xa inhibitor Xarelto meets primary endpoint

cxvascular.com, 5 February 2015
Portola has announced topline results from the first part of the phase 3 ANNEXA-R (Andexanet alfa a novel antidote to the anticoagulant effects of factor Xa inhibitors – rivaroxaban) study, which is evaluating the safety and efficacy of andexanet alfa with the factor Xa inhibitor Xarelto (rivaroxaban).
Read more


Real-world multicentre study shows positive outcomes with left atrial appendage occlusion for stroke prevention in AF

cxvascular.com, 11 February 2015
The largest study using the Amplatzer Cardiac Plug (St Jude Medical) for left atrial appendage occlusion has shown a high procedural success rate and favourable outcomes for prevention of atrial fibrillation-related thromboembolism.
Read more


Implantable cardioverter-defibrillators May Provide Little Benefit When Implanted Over Age 70

hcplive.com, 12 February 2015
Implantable cardioverter-defibrillators (ICDs) may not benefit all patients to the same degree, as their effectiveness seems to diminish somewhat with the advancing age of the patient, according to a review published online Feb. 10 in Circulation: Cardiovascular Quality Outcomes.
Read more


Effectiveness of implanted defibrillators may depend on patient's age

medicalxpress.com, 10 February 2015
Implantable cardioverter-defibrillators (ICDs) prolong survival among heart patients who face a high risk for sudden cardiac death, a new review of research indicates.
Read more


Novel algorithm led to low rate of inappropriate ICD shocks

healio.com, 9 February 2015
A novel discrimination algorithm designed to distinguish between true ventricular arrhythmias and other rhythms was associated with a low rate of inappropriate shocks in patients with single- and dual/triple-chamber implantable cardioverter defibrillators, according to new data from the PainFree SST study.
Read more


Basildon Hospital now running one of the biggest INR self-testing programmes in England

echo-news.co.uk, 6 February 2015
BASILDON Hospital is one of the leading centres for a programme which gives pocketsized monitors to patients at risk of blood clots to test their blood at home.
Read more


An arrhythmia specialist nurse improves patient care in arrhythmias treated with dronedarone

bjcardio.co.uk, February 2015
The European Medicines Agency (EMA) has mandated that patients treated with dronedarone have regular monitoring. An arrhythmia specialist nurse (ASN) took over the care of patients on dronedarone in 2012.
Read more


Experiences from a non-medical, non-catheter laboratory implantable loop recorder (ILR) service

bjcardio.co.uk, February 2015
This paper describes the experiences of developing a non-medical, non-catheter laboratory (cath lab) based implantable loop recorder (ILR) service.
Read more


Comparing the four NOACs

medpagetoday.com, 2 February 2015
With four new oral anticoagulants (NOACs) to chose from, even the most experienced clinicians face a quandary: which NOAC is the best choice for the patient?
Read more


Head CT scans may be overused in Emergency Departments

medscape.com, 2 February 2015
Most patients presenting to the emergency department (ED) with syncope or dizziness may not benefit from a computed tomography (CT) scan of the head unless they are older than 60 years, have a focal neurologic deficit, or have a history of recent head trauma, researchers have found.
Read more


CardioComm solutions to initiate sales of the Heartcheck(TM) ECG Pen device in pharmacies across Canada

marketwatch.com, 2 February 2015
The HeartCheck(TM) PEN will be made available in approximately 602 Shoppers Drug Mart Pharmacies by February 2015 which will coincide with the start of Heart Month.
Read more


FDA approves ablation catheter with flexible tip to treat cardiac arrhythmias

healio.com, 28 January 2015
St. Jude Medical announced that the FDA has approved an ablation catheter with a flexible tip for treatment of patients with cardiac arrhythmias.
Read more


Chinese University of Hong Kong advocates atrial fibrillation screening and drug education to reduce risk of stroke among elderly

healthcanal.com, 28 January 2015
The prevalence of Atrial Fibrillation (AF) grows with the ageing population. According to global research, one in every five people aged 65 years and above will develop AF.
Read more


Diploma in Syncope and Related Disorders at the Royal College of Physicians of Ireland

Syncope Trust And Reflex anoxic Seizures (STARS), January 2015
This course is the initiative of STARS Trustee, Professor Rose Ann Kenny and Dr Conal Cunningham. Already the positive feedback and uptake is more than encouraging. Syncope units must be the way forward for the future and for anyone whose hospital is considering this then early registration of interest for 2015 is recommended.
Learn more


NICE recommends rivaroxaban (Xarelto) to prevent blood clots in people who have had a heart attack in final draft guidance

NICE, 23 January 2015
In final draft guidance published today NICE has confirmed its earlier positive draft decision recommending rivaroxaban (Xarelto, Bayer Healthcare), in combination with clopidogrel and aspirin, or with aspirin alone, as an option.
Read more


AliveCor launches ability to detect a serious heart condition in an ECG on a mobile device

prnewswire.com, 22 January 2015
AliveCor, Inc. announced today it has received CE Mark clearance for its automated analysis process (algorithm) to detect atrial fibrillation (AF), the most common heart rhythm disturbance and a leading cause of stroke. 
Read more


ANNEXA-R: Antidote to novel oral anticoagulant met primary endpoint

healio.com, 17 January 2015
Portola Pharmaceuticals announced topline results of the phase 3 ANNEXA-R study demonstrating that andexanet alfa, an antidote to the anticoagulant effects of Factor Xa inhibitors, met the primary endpoint with high statistical significance.
Read more


Identifying postoperative atrial fibrillation in cardiac surgical patients posthospital discharge, using iPhone ECG: a study protocol

BMJ Open, January 2015
Postoperative atrial fibrillation (AF) occurs in 30–40% of patients after cardiac surgery. Identification of recurrent postoperative AF is required to initiate evidence-based management to reduce the risk of subsequent stroke. However, as AF is often asymptomatic, recurrences may not be detected after discharge.
Read more


1 in 10 patients inappropriately prescribed aspirin to prevent first stroke

medicalnewstoday.com, 14 January 2015
More than 10% of patients in the US receiving low-dose daily aspirin to prevent a first heart attack or stroke are likely to have been prescribed the medication inappropriately.
Read more


AtriCure announces preliminary results for fourth quarter and full year 2014 issues 2015 guidance

businesswire.com, 12 January 2015
AtriCure, Inc., a leading innovator in surgical treatments for atrial fibrillation (“Afib”) and Left Atrial Appendage Management (“LAAM”), today announced preliminary financial results for fourth quarter and full year 2014 and issued 2015 financial guidance.
Read more


Antidote reverses anticoagulation activity of rivaroxaban: ANNEXA-R

medscape.com, 9 January 2015
SAN FRANCISCO, CA — Portola Pharmaceuticals, the makers of an antidote for rivaroxaban (Xarelto, Bayer Pharma/Janssen Pharmaceuticals), a factor Xa inhibitor that is part of the newest generation of oral anticoagulants, announced today that a phase 3 study testing the safety and efficacy of the antidote met its primary end point.
Read more


Syncopal episodes can warn of cardiac conditions

jems.com, 8 January 2015
You’ve been dispatched to care for a person who’s unconscious. As you walk in, you’re directed to a young male lying on a couch.
Read more


New study indicates the likelihood of atrial fibrillation increases with second ablation

hcplive.com, 8 January 2015
Researchers enrolled 95 patients who were about to undergo a second ablation procedure and compared the recorded size of each patient’s left atrium before the first ablation with its size before the second procedure.
Read more


FDA approves edoxaban for use in AF-related stroke prevention
forbes.com, 8 January 2015
Late Thursday the FDA announced that it had approved edoxaban, the new oral anticoagulant manufactured by Daiichi Sankyo.
Read more
Dabigatran carries risk of GI bleeding; risk greater in kidney disease, black patients

medicalresearch.com, 7 January 2015
Medical research: What is the background for this study? What are the main findings?
Read more


Timing of ICD implantation affected adverse events

healio.com, 6 January 2015
Implantable cardioverter defibrillator implantation on a weekday morning was safer than implantation that occurred in the afternoon, evening or on a weekend or holiday.
Read more


CardioFocus partners with Japan lifeline for distribution of the HeartLight Laser Balloon to treat atrial fibrillation

prnewswire.com, 5 January 2015
CardioFocus, Inc., developer of the HeartLight® Endoscopic Ablation System for the treatment of atrial fibrillation (AF), today announced that it has executed an exclusive, multi-year distribution agreement with Japan Lifeline Co., Ltd. 
Read more


Study looks at genetic causes of atrial fibrillation

hcplive.com, 2 January 2015
A new genetic analysis of 239 patients provides the new information about which mutations put people at risk of developing atrial fibrillation (AF)
Read more


Digoxin linked to elevated risk for death, hospitalization in patients with AF

healio.com, 29 December 2014
Data from the ATRIA-CVRN study suggest an association between digoxin and increased risk for death and hospitalization in patients with atrial fibrillation.
Read more


ROCKET AF: Oral anticoagulation yielded stroke-protective benefit in AF, valvular disease

healio.com, 26 December 2014
Oral anticoagulation reduced the risk for stroke in patients with atrial fibrillation, even if they had significant valvular disease, according to new data from the ROCKET AF trial.
Read more


New European atlas on the prevention of AF-related stroke launched

arwatch.co.uk, 19 December 2014
The burden of atrial fibrillation (AF)-related stroke prevention in different countries across Europe is shown by a comprehensive new report – ‘The Route Map for Change and European Atlas on the Prevention of AF-related Stroke’ – released recently the Arrhythmia Alliance.
Read more


Lower stroke risk with paroxysmal AF?

medscape.com, 15 December 2014
More evidence suggesting that intermittent atrial fibrillation (AF) may be associated with a lower risk for stroke compared with permanent AF has come from a new systematic review of the literature.
Read more


Working Life: Dr Dermot McCaffrey, consultant cardiologist, Beacon Hospital

irishexaminer.com, 13 December 2014
A day in the life of Dr Dermot McCaffrey.
Read more


Why the sudden onset bruising in a previously stable warfarin patient?

medscape.com, 12 December 2014
A 72-year-old man is your last patient of the day. He is visiting his daughter, a patient of yours, who asks you to see him.
Read more


Atrial fibrillation specific follow-up plan improves post-discharge survivability

hcplive.com, 12 December 2014
Research shows that a follow-up strategy designed specifically for patients who visit the hospital with atrial fibrillation (AF) reduces future admissions and patient deaths more than a general follow-up plan.
Read more


Newer ICD leads associated with low rates of mechanical failure

healio.com, 12 December 2014
Optim-insulated implantable cardioverter defibrillator leads had low rates of all-cause mechanical failure and no observed externalized conductors in a registry study.
Read more


How useful is the RED-AF tool for improving outcomes in patients with atrial fibrillation?

hcplive.com, 10 December 2014
Researchers from Vanderbilt University have developed a new tool for deciding when hospitals should admit patients with symptomatic atrial fibrillation (AF) and when they should send them home.
Read more


Dual-chamber settings in ICDs reduced risk for inappropriate shock

healio.com, 11 December 2014
Compared with single-chamber settings, dual-chamber settings for implantable cardioverter defibrillators were associated with reduced risk for inappropriate shock without increases in morbidity and mortality, according to the results of the OPTION study.
Read more


Biotronik completes full-body ProMRI pacemaker trial

zenopa.com, 11 December 2014
Biotronik has announced the completion of the latest phase of its new ProMRI study, which assesses cardiovascular medical technology equipped with its ProMRI technology.
Read more


Reducing the risk of sudden cardiac arrest during sports

news-medical.net, 11 December 2014
Time and again, the topic of sudden cardiac death grabs the public's attention when football stars or other top athletes collapse from cardiac arrest in front of the live cameras.
Read more


Risk of mortality and cardiovascular outcomes among patients newly diagnosed with atrial fibrillation

BJCardio.co.uk, December 2014
This study aimed to assess mortality and cardiovascular (CV) outcomes of patients with newly diagnosed atrial fibrillation (AF) managed in the UK primary care setting.
Read more


Real-world use affirms NOAC safety profile

medpagetoday.com, 9 December 2014
The bleeding risk profile seen with dabigatran (Pradaxa) and rivaroxaban (Xarelto) in trials of prevention in atrial fibrillation was affirmed in real-world practice.
Read more


BIOTRONIK Announces Conclusion of Full-Body ProMRI Pacemaker Study

businesswire.com, 9 December 2014
BIOTRONIK, a leading manufacturer of cardiovascular medical technology, announced today that Phase B of its ProMRI® study has completed patient enrollment and concluded all planned scans. This phase of the study is investigating the safety of Entovis pacemakers in patients who undergo full-body magnetic resonance imaging (MRI) scans, including cardiac and thoracic spinal scans.
Read more


Study examines patients’ perspectives on deactivation of implantable defibrillators in end-of-life scenarios

dicardiology.com, 5 November 2014
Most patients with implantable cardioverter defibrillators (ICDs) haven’t thought about device deactivation if they were to develop a serious illness from which they were not expected to recover. But given changes in healthcare, there may be a new reason to do so.
Read more


Survey: Doctors believe patients with AF underestimate stroke risk, impact

healio.com, 5 December 2014
Many physicians said they believe that patients with atrial fibrillation underestimate the effect of atrial fibrillation-related stroke on their daily lives and underestimate their risk for ischemic stroke, according to the results of a new survey.
Read more


Unlocking the potential of NOACs

BJCardio.co.uk, December 2014
When the NOACs (novel oral anticoagulants) were introduced over three years ago, they promised to revitalise the management of conditions such as atrial fibrillation (AF), venous thromboembolism (VTE) and thromboprophylaxis after major joint replacement surgery.
Read more


Stroke prevention project in Bradford highlighted in European report

telegraphandargus.co.uk, 4 December 2014
A HIGH-PROFILE European report is highlighting a project being pioneered in Bradford to help prevent strokes in people with a common heart rhythm disorder.
Read more


iRhythm Technologies Receives CE Mark for ZIO® Service, Enters First International Market with CardioLogic Ltd Partnership in United Kingdom

prnewswire.com, 3 December 2014
iRhythm Technologies, Inc., a leading digital health care solutions company focusing on the advancement of cardiac care, today announced that it has secured a CE mark (Conformite Europeenne) for the ZIO Service, enabling the company to market its long-term continuous heart monitoring solution in Europe.
Read more


Epinephrine hurts cardia carrest survival?

medpagetoday.com, 2 December 2014
Epinephrine (adrenaline) given before hospital arrival for cardiac arrest was associated with poorer chances of survival without substantial mental disability, an observational study showed.
Read more


Cryoballoon procedure quicker to perform than coventional ablation

MailOnline.co.uk, 2 December 2014
Atrial fibrillation — an erratic heartbeat — affects up to 800,000 Britons, and can lead to a stroke if left untreated.
Read more


ARREST-AF study shows reducing bad lifestyle choices helps improve long-term success rates of ablation procedures for AF

medpagetoday.com, 1 December 2014
Aggressively tackling weight, blood pressure, and other cardiovascular risk factors improved the long-term success of ablation procedures for atrial fibrillation, the ARREST-AF study showed.
Read more


Biotronik's new ProMRI ICDs and CRT-Ds unveiled

medgadget.com, 1 December 2014
BIOTRONIK announced that it is releasing a new line of ProMRI implantable cardioverter defibrillators (ICDs) and cardiac resynchronization therapy defibrillators (CRT-Ds).
Read more


New study on warfarin use in treatment of AF

hcplive.com, 30 November 2014
For patients diagnosed with atrial fibrillation, one of the more popular treatment courses is warfarin.
Read more


GPs urged to discontinue aspirin in stable CAD patients with atrial fibrillation

pulsetoday.co.uk, 24 November 2014
GPs have been cautioned against continuing aspirin long-term in patients with stable coronary artery disease (CAD) who are also receiving anticoagulation therapy for stroke prevention.
Read more


Findings of PROTECT AF study at 4 years show LAA closure maintains efficacy over warfarin

tctmd.com, 20 November 2014
Adding another layer to the body of evidence, 4-year results from the PROTECT AF trial showing better efficacy for patients with nonvalvular atrial fibrillation (A-fib) using percutaneous left atrial appendage (LAA) closure compared with warfarin were published in the November 19, 2014, issue of the Journal of the American Medical Association.
Read more


Job vacancy: Anticoagulant Nurse Practitioner

The Royal Liverpool and Broadgreen University Hospitals, November 2014
Band 7, closes 3 December 2014
The Royal Liverpool and Broadgreen University Hospitals NHS Trust is one of the largest and busiest hospital trusts in the North of England with an annual budget of over £300 million, more than 7,000 staff and almost one million patients being seen every year. We employ approximately 300 consultants, many of whom have honorary senior lecturer contracts with the University of Liverpool.
Learn more


New study investigates patient perspectives on deactivation of ICDs at the end of life

news-medical.net, 18 November 2014
Findings point to need for advance care planning around device deactivation
Read more


Penn study examines patients' perspectives on deactivation of implantable defibrillators in end-of-life scenarios

healthcanal.com, 18 November 2014
Findings point to need for advance care planning around device deactivation.
Read more


Anticoagulation highlights from ESC 2014

BJCardio.co.uk, November 2014
Much of the European Society of Cardiology (ESC) 2014 Congress programme was devoted to important clinical issues such as management of arrhythmia, and stroke prevention in non-valvular atrial fibrillation (NVAF).
Read more


Overuse of anticoagulants raises dementia risk in AF patients

gponline.com, 16 November 2014
Long-term overtreatment with anticoagulants combined with antiplatelet therapy to prevent stroke could increase the risk of dementia in patients with AF, researchers have found.
Read more


Drug lowers high potassium levels associated with potentially lethal cardiac arrhythmias

medicalxpress.com, 17 November 2014
Mikhail Kosiborod, M.D., of Saint Luke's Mid America Heart Institute, Kansas City, and colleagues evaluated the efficacy and safety of the drug zirconium cyclosilicate in patients with hyperkalemia (higher than normal potassium levels).
Read more


CCGs in the dark about demand for, and quality of, anticoagulation services

onmedica.com, 17 November 2014
Clinical Commissioning Groups are in the dark about how many people in their local area are at risk of a stroke caused by an abnormal heartbeat, or the quality of services provided to treat them, finds a new report* issued by charity AntiCoagulation Europe (ACE).
Read more


Relative value of clinical outcomes with anticoagulants varies among patients

medscape.com, 13 November 2014
In an assessment of the relative value and weight of clinical events associated with anticoagulant therapy, not all outcomes are created equally in the minds of patients, according to the results of a unique experiment.
Read more


A pacemaker powered by heart motion is being developed

cxvascular.com, 13 November 2014
Researchers in Switzerland are developing a pacemaker which has no leads and no battery. With this in mind, the prototype is aimed to solve two of the major problems with traditional pacemakers.
Read more


Continuous ECG surveillance of marathon athletes is feasible

cxvascular.com, 13 November 2014
Online electrocardiogram (ECG) continuous surveillance during marathon running is feasible, according to a study presented at the European Congress on e-Cardiology and e-Health (29–31 October, Bern, Switzerland).
Read more


AliveCor® to showcase the AliveCor Heart Monitor at the American Heart Association scientific sessions

prnewswire.com, 15 November 2014
AliveCor, Inc. announced today its attendance at the American Heart Association Scientific Sessions taking place at McCormick Place in Chicago, Ill. from November 15-19.
Read more


AF associated with accelerated renal disease

hcplive.com, 15 November 2014
A common arrhythmia in older adults is more common in those with chronic kidney disease (CKD) and may speed progression to the need for kidney dialysis or transplant, according to Nisha Bansal, MD.
Read more


Study finds link between AF and Silent Cerebral Infarctions

hcplive.com, 12 November 2014
A meta-analysis of many older studies may explain the recent observation that patients with atrial fibrillation (AF) frequently suffered cognitive impairment without suffering from any signs of stroke.
Read more


New blood test reveals risk of AF and stroke

hcplive.com, 10 November 2014
New research suggests that a simple blood test could identify people with a genetic predisposition towards atrial fibrillation (AF) and justify prophylactic treatment to cost-effectively prevent strokes.
Read more



New plan to send more patients wiith AF home

medscape.com, 6 November 2014
A new clinical tool could help physicians decide which patients with symptomatic atrial fibrillation can safely be sent home from the emergency department, according to a new study.
Read more


Another antidote for new oral anticoagulants advances in phase 1 study

medscape.com, 6 November 2014
It took about 10 minutes for a single 100- to 300-mg dose of a synthetic anticoagulant antidote to mostly restore clotting time prolonged by 60 mg of edoxaban (Savaysa, Daiichi Sankyo), a new oral anticoagulant (NOAC) that seems destined to soon join others on the market, in a phase 1 study reported preliminarily this week.
Read more


Three wearables that could change AF screening

medpagetoday.com, 5 November 2014
In this 3-part series, we'll look first at current screening strategies and some of the limitations that create an opportunity for emerging tools. Then we'll dive into some of the tools that will define the next generation of atrial fibrillation screening.
Read more


Defibrillator implantation riskier on afternoons, weekends

medscape.com, 5 November 2014
Defibrillator-implantation procedures are associated with worse in-hospital outcomes when they're performed on weekends and afternoons than on weekdays and mornings, a new study shows.
Read more


Smartphone screening for AF?

medpagetoday.com, 4 November 2014
In this three-part series, we'll look first at current screening strategies and some of the limitations that create an opportunity for emerging tools. Then we'll dive into some of the tools that will define the next generation of atrial fibrillation screening.
Read more


AF poised as mobile health success story

medpagetoday.com, 3 November 2014
In this 3-part series, we'll look first at current screening strategies and some of the limitations that create an opportunity for emerging tools. Then we'll dive into some of the tools that will define the next generation of atrial fibrillation screening. This is part 1.
Read more


Job vacancy: Anticoagulant Database and Centre Coordinator

Cambridge University Hospitals, November 2014
The outpatient anticoagulant service wishes to recruit a highly motivated person to join their team as a data manager. The service provides care for over 5,000 anticoagulated patients in the community, and is committed to admission avoidance, and transferring care safely into the community after hospitalization.
Read more


AtriCure announces upcoming investor conference schedule

businesswire.com, 31 October 2014
AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments for atrial fibrillation and Left Atrial Appendage Management, today announced that it will present at the Stifel Healthcare Conference 2014 at the Palace Hotel in New York City on Tuesday, November 18, 2014.
Read more


FDA panel endorses edoxaban as fourth NOAC

medpagetoday.com, 31 October 2014
Edoxaban (Savaysa) should be approved for stroke and systemic embolism prevention in nonvalvular atrial fibrillation, an FDA advisory panel recommended Thursday.
Read more

 

FDA gives edoxaban favourable review prior to advisory committee meeting

medscape.com, 29 October 2014
SILVER SPRING, MD — Food and Drug Administration (FDA) officials charged with the task of reviewing edoxaban (Savaysa, Daiichi-Sankyo) in advance of tomorrow's advisory committee meeting are recommending the novel anticoagulant be approved for the treatment of patients with atrial fibrillation (AF).
Read more


Improve atrial fibrillation care to stave off 11,000 strokes every year, GPs told

onmedica.com, 30 October 2014
Improving the care of people with abnormal heart rhythms (atrial fibrillation) could stave off more than 11,000 strokes and save the NHS up to £124 million every year, finds a new economic analysis* of using warfarin to help prevent stroke from NHS Improving Quality.
Read more


VIDEO: Evolution in catheter ablation of persistent AF, HRC 2014

Arrhythmia & Electrophysiology Review, Heart Rhythm Congress 7 October 2014
Arrhythmia and Electrophysiology Review (AER) Interview with Mark O'Neill, Kings College, London, UK on the evolution in catheter ablation of persistent AF.
View interview


VIDEO: The subcutaneous ICD - a revolutionary tool for prevention of sudden cardiac death

Arrhythmia & Electrophysiology Review, Heart Rhythm Congress, 7 October 2014
Arrhythmia and Electrophysiology Review (AER) Interview with Andrew Grace, University of Cambridge on the subcutaneous ICD - a revolutionary tool for prevention of sudden cardiac death.
View interview


AliveCor honored as one of FierceMedicalDevices' Fierce 15 most promising private medical and diagnostic companies in the world

prnewswire.com, 21 October 2014
AliveCor, Inc. announced today that the company has been named one of the Fierce 15 most promising privately held medical device and diagnostic companies in the world.
Read more


Three ways to prevent sudden heart death in fit, young athletes

medicalxpress.com, 21 October 2014
Fifteen year-old Marshall Hastings is living proof of the value of having life-saving cardiac defibrillators and trained personnel at sporting events.
Read more


Liverpool Cardiologist Receives Outstanding National Award

Liverpool Hospitals, 20 October 2014
A heart specialist at Liverpool Heart and Chest Hospital has been recognised nationally for his work in caring for patients with abnormal heart rhythms (arrhythmias).
Read more


Amiodarone use increased stroke, systemic embolism risk in patients with AF

healio.com, 20 October 2014
Patients with atrial fibrillation who received amiodarone at baseline in the ARISTOTLE trial, besides apixaban or warfarin, had an increased risk for developing stroke or systemic embolism and had a shorter time in the therapeutic range compared with patients who did not receive amiodarone, according to a new analysis.
Read more


Rose Medical Center experts perform LARIAT procedure for patients with atrial fibrillation

news-medical.net, 16 October 2014
Rose Medical Center is now performing a groundbreaking procedure for patients with atrial fibrillation (AFib) that may reduce their risk for stroke when they cannot take blood thinners due to special circumstances.
Read more


New guidelines for postoperative atrial fibrillation: key points for pharmacists

pharmacytimes.com, 14 October 2014
The American Association for Thoracic Surgery recently published new recommendations for the prevention and management of atrial fibrillation (AF) and flutter in patients undergoing thoracic surgery.
Read more


Check the pulse to track irregular heartbeats after a stroke, from the October 2014 Harvard Heart Letter

digitaljournal.com, 14 October 2014
The rapid, irregular heartbeat known as atrial fibrillation is a key cause of stroke. New research suggests that it's to blame for more strokes than doctors realized, and that simply measuring the pulse could help detect unrecognized atrial fibrillation and avert a second stroke, reports the October 2014 Harvard Heart Letter.
Read more


Pharma supports first World Thrombosis Day

pmlive.com, 13 October 2014
The first World Thrombosis Day takes place today with supporters including several pharma companies.
Read more


Patients with recurrent AF more likely to have kidney function decline

medicalresearch.com, 13 October 2014
An interview with Dr Jelena Kornej, Department of Electrophysiology, Heart Centre, Leipzig, Germany.
Read more


AtriCure completes enrollment in post approval study for the synergy™ ablation system

businesswire.com, 9 October 2014
AtriCure, Inc., a leading innovator in surgical treatments for atrial fibrillation (Afib) and left atrial appendage management (LAAM), today announced enrollment in the ABLATE Post Approval Study (PAS) is complet
Read more


Comorbities will be considered in future ACC/AHA Guidelines

healio.com, 8 October 2014
American College of Cardiology/American Heart Association clinical practice guidelines in the future will discuss the applicability and quality of recommendations for the most frequent comorbidities related to the CV condition addressed, according to a new statement from the ACC, the AHA and the US Department of Health and Human Services.
Read more


FDA Advisory Committee Panel Votes In Favor Of The WATCHMAN™ Left Atrial Appendage Closure Device

marketwatch.com, 8 October 2014
After reviewing updated data and analysis for the Boston Scientific Corporation BSX, -1.81% WATCHMAN™ Left Atrial Appendage Closure (LAAC) Device, the U.S. Food and Drug Administration (FDA) Circulatory System Devices Panel of the Medical Devices Advisory Committee voted in favor of the Device. By a vote of 6 to 5 (with 1 abstention) the Panel concluded that the benefits of the WATCHMAN Device outweigh the potential risks.